Riskpilot← Back to searchSign inGet full accessAmandakliniken AB
ABActiveOrg 5568193279Berguddsvägen 54Beauty care and other beauty treatment activities · NACE 9622Est. 20101 employees
Revenue 2025
SEK 3,4M
-10% vs 2024
EBITDA margin
32.0%
-26% vs 2024
Equity ratio
60.7%
Financial strength
Net profit 2025
SEK 769K
-27% vs 2024
| Revenue | SEK 3,4M | -10% |
| EBITDA | SEK 1,1M | -26% |
| Net profit | SEK 769K | -27% |
| Total assets | SEK 6,4M | +12% |
| Equity | SEK 3,9M | +14% |
| Employees | 1 | — |
Legal name
Amandakliniken AB
Org number
5568193279
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
20 september 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva öppen sjukvårdsmottagning.
Address
Berguddsvägen 54
Email
info@amandakliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 431 | 3 710 | 3 586 | 3 761 | 3 393 |
| Staff expenses | — | −978 | — | — | −1 223 |
| EBITDA | 1 189 | 1 599 | 1 542 | 1 469 | 1 086 |
| Depreciation & amort. | −10 | −32 | −32 | −35 | −55 |
| EBIT | 1 179 | 1 567 | 1 510 | 1 434 | 1 031 |
| Net financials | −2 | −1 | 19 | 315 | 2 |
| Profit before tax | 927 | 1 175 | 1 146 | 1 349 | 983 |
| Tax | −192 | −248 | −242 | −289 | −213 |
| Net profit | 735 | 928 | 904 | 1 060 | 769 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 689 | 3 501 | 4 583 | 5 671 | 6 368 |
| Equity | 1 202 | 1 930 | 2 633 | 3 394 | 3 863 |
| Long-term debt | 66 | 28 | 52 | 0 | — |
| Short-term debt | 672 | 403 | 373 | 352 | 530 |
| Total debt | 738 | 431 | 425 | 352 | 530 |
EBITDA margin
32.0%
This company
15.8%
Market median
+103% vs market
20212025
Equity ratio
60.7%
This company
38.2%
Market median
+59% vs market
20212025
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
22.7%
This company
8.1%
Market median
+180% vs market
20212025
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20212025
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BT Audit | Audit | 2023 |
AD Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2023 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Amandakliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Tommy Jonasson | Audit | 0 companies |
| Amanda Dussina Rasmussen Siberg | Chief Executive Officer | 0 companies |
| Marie-Louise Siberg | Deputy Board Member | 0 companies |
| Anders William Siberg | Board of Directors | 0 companies |
| Bernt William Taengh | Deputy Board Member | 0 companies |
| Lars Erik Elvroth | Deputy Board Member | 0 companies |